4Zhang LX,Tu DH,He GX, et al. Risk of tuberculosis infection and tuberculosis meningitis after discontinuation of BCG in Beijing[J]. Am J Respir Crit Care Med, 2000,162:1314～1317
5IUAT Commitee on Prophlaxis. Efficacy of various duration of isoniazid prevetive therapy to tuberculosis:five years of follow up in the IUAT trial[M]. Bull WHO, 1982,60:555～64
6Hong Kong Chest Service/Tuberculosis Research Centre, British Medical Research Council. A double-blind placebo-controlled Clinical of three anti tuberculosis chemoprophylaxia regimens in patients with silicosis in Hong Kong[J]. Am Respir Dis, 1992,145:36～41
7Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommen dations Against the Use of Rifampin and Pyrazinamide for Treatment of Letent Tuberculosis Infection-United States 2003[J]. MMWR 2003,52:735～739
8Watkins RE, Brennan R, Plant AT. Tuberculin reactivity and the risk of tuberculosis a review[J]. Int J Tuberc Dis, 2000,4:895～903
9张贺秋,赵雁林.现代结核病诊断技术.北京:人民卫生出版社,2013:47-103.
10World Health Organization. Global tuberculosis report 2012 [EB/OL]. 2013 [2013-07-10] http://www. who. int/tb/ publications/global report/en/.
